Does NIVOLUMAB Cause Soft tissue infection? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Soft tissue infection have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.0% of all adverse event reports for NIVOLUMAB.
23
Reports of Soft tissue infection with NIVOLUMAB
0.0%
of all NIVOLUMAB reports
5
Deaths
22
Hospitalizations
How Dangerous Is Soft tissue infection From NIVOLUMAB?
Of the 23 reports, 5 (21.7%) resulted in death, 22 (95.7%) required hospitalization, and 7 (30.4%) were considered life-threatening.
Is Soft tissue infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Soft tissue infection?
METHOTREXATE (129)
PREDNISONE (105)
CYCLOPHOSPHAMIDE (98)
RITUXIMAB (98)
MYCOPHENOLATE MOFETIL (81)
VINCRISTINE (76)
DEXAMETHASONE (70)
TACROLIMUS (68)
DOXORUBICIN (64)
CYCLOSPORINE (53)
Which NIVOLUMAB Alternatives Have Lower Soft tissue infection Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE